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A case of common variable immunodeficiency
disease and thyroid amyloidosis
Abstract: A 37-year-old male patient with fever, mild respiratory distress, diffuse goiter, and
hepatosplenomegaly was admitted to our hospital. Clinical and laboratory findings showed that he
had recurrent respiratory tract infections—namely bronchiectasis—due to common variable
immunodeficiency disease (CVID) and AA-type amyloid deposition in the thyroid gland.
Although recurrent infections as a consequence of inadequate gammaglobulin (IVIG) substitution
therapy are regarded as the main cause of the development of amyloidosis, amyloidosis in a patient
with hypo/agammaglobulinemia is extremely rare. In this report we discuss the association of
CVID and recurrent respiratory tract infections with secondary amyloidosis restricted to one
organ, the thyroid gland, which is an uncommon site for amyloid deposition.
Key Words: Common variable immunodeficiency, thyroid, amyloidosis

Yaygın değişken immun yetmezlik hastalığı ve
tiroid amiloidozu olan bir olgu
Özet: Otuzyedi yaşında erkek hasta ateş, hafif düzeyde solunum sıkıntısı, difüz guatr ve
hepatosplenomegali bulgularıyla hastaneye kabul edildi. Klinik ve laboratuvar bulguları hastanın
yaygın değişken immun yetmezlik hastalığına (YDIYH) bağlı tekrarlayan solunum yolu
enfeksiyonlarının, bronşektazisinin, ve tiroid bezinde AA tipi amiloid birikiminin olduğunu
gösterdi. Tekrarlayan enfeksiyonlarda gamaglobulin (IVIG) ile yetersiz tedavinin amiloidoz
gelişmesinin başlıca nedeni olduğu şeklinde görüş bulunsa da, hipo veya agamaglobulinemili
hastalarda amiloidoz görülmesi oldukça nadirdir. Bu makalede biz, YDIYH ve tekrarlayan
solunum yolu enfeksiyonları ile tek bir organa, tiroid bezine, sınırlı sekonder amiloidozun
birlikteliğini amiloid birikiminin nadir görüldüğü bir yer olması nedeni ile tartıştık.
Anahtar Sözcükler: Yaygın değişken immun yetmezlik, tiroid, amiloidoz
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Introduction
Common variable immunodeficiency (CVID) is a primary immunodeficiency disease characterized by decreased (or absent) immunoglobulin level,
and recurrent bacterial infections of the respiratory and gastrointestinal tracts
due to highly virulent encapsulated extracellular bacteria, which is most
commonly seen in adolescents and young adults (1-5). Patients with CVID may
also present with signs and symptoms suggestive of lymphoid malignancy,
including fever, weight loss, anemia, thrombocytopenia, splenomegaly,
generalized lymphadenopathy, and lymphocytosis (6).
The underlying problem is a failure of B cells to differentiate into plasma cells
that secrete Igs. The mechanisms suggested to be responsible for this failure have
included an intrinsic defect in B cells resulting in abnormal terminal
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differentiation, deranged T-cell regulation with
either too much suppressive activity or too little
helper activity, or in rare cases the presence of
autoantibodies to T or B cells (2,3,5).
Amyloidosis in a patient with hypo/
agammaglobulinemia is extremely rare (7).
Amyloidosis is a group of diseases, all characterized
by deposition of protein fibrils with a β-sheet
structure. Amyloid fibrils are derived from different
protein precursors and variation in the clinical
picture of systemic amyloidosis is related to the type
of precursor involved (8,9).
We describe herein a patient with recurrent
respiratory tract infections induced by
hypogammaglobulinemia and associated with AAtype amyloidosis of the thyroid gland.
Case Report
A 37-year-old man with a medical history of
recurrent respiratory tract infections that began
when he was 15 years old was referred to our
hospital for the evaluation of his goiter. Upon
hospital admission the patient was alert,
malnourished, and had mild respiratory distress
with fever.
Physical examination
On physical examination his BP was 110/70
mmHg, heart rate was 108 beats/min and regular,
respiratory rate was 28 breaths/min, oxygen
saturation was 92% on room air, and body
temperature was 38 °C. The thyroid gland was
palpable. Lung examination revealed prolonged
expiration with bilateral scattered rhonchi and
decreased respiratory sounds in the lower lung
fields. Cardiac examination was unremarkable.
Abdominal
examination
revealed
hepatosplenomegaly. The patient did not have
diarrhea. Bilateral minimal pedal edema was
observed.
Laboratory findings
The patient’s WBC count was 10.8 × 103 cells/μl
(neutrophils 73%) and hemoglobin level was 11.7
g/dl. Creatinine clearance was 89 ml/min. Plasma
albumin concentration was 4.2 g/dl (normal: 3.5-5.0
g/dl), globulin concentration was 1.4 g/dl (normal:
468
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1.1-3.5 g/dl). Protein electrophoresis results were as
follows: albumin, 69.1% (normal: 60%-71%); alpha1 globulin, 4.8% (normal: 1.4%-2.9%); alpha-2
globulin, 15.2% (normal: 7%-11%); beta globulin,
9.9% (normal: 8%-13%); gammaglobulin, 1.0%
(normal: 11%-18.6%). Serum IgG level was 0 mg/dl
(normal: 540-1822 mg/dl), IgM was 0 mg/dl
(normal: 22-240 mg/dl), and IgA was 2 mg/dl
(normal: 63-484 mg/dl). Serum and urine
immunoelectrophoresis for kappa and lambda light
chains were negative. C3 and C4 complement levels
were normal—95 mg/dl and 25 mg/dl, respectively.
Beta-2 microglobulin was negative (normal: < 0.22
mg/dl).
The erythrocyte sedimentation rate (ESR) was 42
mm/h; hsCRP was 12.5 mg/l (normal: 0-5 mg/l); RF
was negative. Thyroid function test results were
within normal ranges: free T3, 2.27 pg/ml; free T4,
1.10 ng/dl; TSH, 2.51 μIU/ml. Antibodies directed
against microsomes (TPO) were 8.3 IU/ml (normal
0-60 IU/ml), against thyroglobulin (anti T) were
54.3 IU/ml (normal 0-60 IU/ml), and against TSH
receptor (TRAb) were 8 U/l (normal 0-9 IU/ml).
Antinuclear antibody, cytoplasmic and
perinuclear antineutrophilic cytoplasmic antibodies,
anti-ds DNA antibody, autoantibodies for
autoimmune hepatitis, and antigliadin IgA and IgG
were negative.
Fungal serology for aspergillosis and serology for
HBV, HCV, HIV, HSV, CMV, EBV, toxoplasma,
rubella, Salmonella typhi, and Brucella mellitensis
were negative. Tuberculin skin test was negative (6
mm induration). Acid-fast bacilli in sputum smears
and sputum culture for mycobacterium tuberculosis
in Lowenstein media were negative. Sputum
cultures revealed Pseudomonas aeruginosa and
Escherichia coli on separate occasions. Stool culture
was negative for ova and parasites.
Fine needle aspiration biopsy of the thyroid
gland showed amorphous eosinophilic material of
amyloid deposition within the gland, which stained
positive with Congo red. Biopsy samples from the
rectum, and subcutaneous tissue of the abdomen
and bone marrow were negative for amyloid
staining. A bone marrow specimen showed no signs
of plasma cell dyscrasias.
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Radiographic findings
High resolution computed tomography (HRCT)
of the lungs revealed bilateral bronchiectasis and
mediastinal and hilar lymphadenopathy < 10 mm.
Abdominopelvic CT showed mild, diffuse
hepatosplenomegaly, but no other pathological
findings. Both US and scanning of the thyroid
showed grade 4 diffuse enlargement of the gland, the
former with a heterogeneous parenchyma and the
latter
with
decreased
tracer
uptake.
Echocardiography showed moderate pulmonary
hypertension (mean pulmonary artery pressure: 50
mmHg) with mild tricuspid regurgitation and right
heart dilatation. The ECG was normal.
Clinical course
Based on sputum culture results, cefepime (1
g/day, bid, IV) was commenced.
The patient could not perform the pulmonary
function tests with a spirometer; therefore, he was
followed-up with arterial blood gas analysis.
Although his clinical condition did not improve,
antibiotic therapy was discontinued after 4 weeks
because the repeated cultures were negative.
Intravenous immunoglobulin replacement of 400
mg/kg once every 3 weeks was continued during the
course.
By the end of the sixth week of hospitalization the
patient underwent total thyroidectomy due to
pressure exerted on his trachea and esophagus
caused by grade 4 diffuse enlargement of the thyroid
gland (Figures 1 and 2). Two weeks postsurgery Lthyroxin (25 μg/day, po) was started.
A rise in the patient’s body temperature and a
recurrent productive cough led to our repeating
sputum cultures and HRCT. Bilateral bronchiectasis
with minimal pleural effusion on the right lung, and
emphysematous bulla on the medial lobe and lingula
with secondary fibrotic changes were evident.
Sputum cultures revealed methicillin-resistant
Staphylococcus aureus (MRSA) and vancomycin (1
g/day, bid, IV) was commenced.
By the end of the third month of hospitalization
the patient developed severe respiratory failure and
was then supported by mechanical ventilation. He
also suffered from generalized convulsions and
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phenytoin (100 mg/day, tid) was administered
through a nasogastric tube. Despite treatment with
appropriate therapeutic doses of IVIG and antibiotic
regimens based on microbiological findings, the
patient died of severe sepsis 3 months after his
admission to the hospital.
Histological findings
The thyroid gland appeared yellowish in
macroscopic cross-sectional view. The thyroid
gland’s follicular structure, with an amorphous,
homogeneous pink substance, was established based
on H&E staining (Figure 3). Histological findings of
the thyroidectomy material stained with Congo red
showed that the amorphous eosinophilic material
within the subepithelium of the thyroid follicles and
walls of the sinusoidal capillaries was amyloid
deposition (Figures 4 and 5).
Forward examination with monoclonal
antibodies against serum amyloid A protein (SAA)
showed that the deposits of amyloid seen in the
subepithelial border of the follicles and walls of the
sinusoidal capillaries were AA amyloid (Figure 6).
Following this finding, mutations of the MEFV gene
of M694V and V726A were studied and deemed
negative. These mutations are associated with
familial Mediterranean fever (FMF) and with AA
amyloidosis (10).
Discussion
Common variable immunodeficiency disease,
also known as idiopathic, congenital non-x-linked,
acquired, or late-onset hypogammaglobulinemia, is
a heterogeneous disorder characterized by low
serum levels of IgG, IgA, and IgM, inability to form
antibodies to antigen, and the absence of gross
defects in cell-mediated immunity (2,3,6).
Importantly, more than 50% of patients have T-cell
abnormalities, including decreased lymphocyte
response to mitogens and microbial antigens (1).
Patients with hypogammaglobulinemia are
susceptible to repeated and persistent infections,
especially bacterial pneumonia, bronchitis, and
sinusitis (2,7). The involved pathogens are typically
virulent encapsulated extracellular organisms, such
as
Haemophilus
influenzae,
Streptococcus
469
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Figure 1. Macroscopic appearance of the thyroid gland after
surgery.

Figure 2. Cross-sectional view of the thyroid gland.

Figure 3. Follicular structure of the thyroid and the amorphous,
homogeneous pink substance (H&E stain, 100×).

Figure 4. Thyroid biopsy specimen shows amorphous eosinophilic
material (amyloid) deposited within the subepithelium of
the thyroid follicles and walls of the sinusoidal capillaries
(Congo red, 100×).

pneumoniae, and Staphylococcus aureus, followed by
Pseudomonas aeruginosa (2,3,5). Bronchiectasis is
also considered a typical feature in patients with Bcell disorders (2,3). In our patient the extent of this
abnormality was indicated by HRCT results, and
Pseudomonas aeruginosa and Escherichia coli were
determined to be the responsible microorganisms of
his respiratory tract infection.

electrophoresis and quantitative measurement of
serum Igs.

The discrepancy between our patient’s low total
serum protein and the normal level of albumin
raised the suspicion of globulin deficiency; this
diagnosis was validated based on serum protein
470

The radiographic and laboratory findings of the
patient excluded the presence of any type of
neoplasia, especially hematological disease. The
incidence of malignant lesions increases
considerably
in
patients
with
primary
immunodeficiency disorders (3,6). Autoimmune
diseases, such as idiopathic thrombocytopenic
purpura, RA, SLE, primary biliary cirrhosis, and
thyroid abnormalities, have been reported to occur
in 20% of these patients in anecdotal reports (3).
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Figure 5. Apple-green birefringence of massive amyloid deposition
beneath the follicle cells and within the walls of the blood
vessels of the thyroid gland, as seen with polarized light
(Congo-red, 100×).

Figure 6. Thyroid biopsy specimen with AA amyloidosis. Deposits
of AA amyloid are seen in the subepithelial border of the
follicles and walls of the sinusoidal capillaries. Amyloid is
brown in the immunoperoxidase stain with monoclonal
antibodies against SAA (amyloid A component Ab-1
(clone mcl) ×200).

Underdiagnosis, diagnostic delay, and
management with a variety of methods contribute to
morbidity and early mortality. There is an average
diagnostic delay of 2.5 years in children and 5.5
years in adults (4). Morbidity is most commonly due
to acute or chronic respiratory infections that lead to
respiratory failure, as in our patient, with a mean age
at death of 28.8 years among males (4), although our
patient died at the age of 35 years.

process by which these fibrils are produced appears
to be multifactorial and differs amongst the various
types of amyloid. In reactive systemic (secondary
AA) amyloidosis, which is related to chronic
inflammatory disorders and chronic infection,
clinical features depend on the nature of the
underlying disorder. AA amyloidosis often presents
with renal disease, autonomic neuropathy,
hepatomegaly, and splenomegaly. Macroglossia is
not a feature and cardiac involvement is rare
(8,9,11). In AL amyloidosis (immunoglobulin light
chain-associated or primary) there is a clonal
dominance of amyloid light (AL) chains—either the
dominant κ or λ isotypes—which are excreted in
urine (Bence Jones proteins). This type of amyloid is
often associated with lymphoproliferative disorders,
such
as
myeloma,
Waldenström’s
macroglobulinemia, or non-Hodgkin’s lymphoma.
It rarely occurs before the age of 40 years (11).
Clinical manifestations are very diverse and include
cardiomyopathy, nephrotic syndrome, renal failure,
orthostatic hypotension, diarrhea, peripheral and
autonomic neuropathy, carpal tunnel syndrome,
and macroglossia (about 10%) (8,11). Deposition of
amyloid can be localized (restricted to one organ or
site of the body) or systemic (in various organs and
tissues throughout the body), and diagnosis is based
on proof of its presence in tissue (8,9). In our case

To lower the morbidity and mortality rates in
CVID early identification of respiratory tract
infections, providing logical antibiotic treatment
based on microbiological findings, and optimization
of IVIG dosage should be considered for each
patient. The appropriate therapeutic dosage of IVIG
is reported to be 300-400 mg/kg once every 3-4
weeks, although there are still some conflicting
results (5). As a case of delayed diagnosis, our
patient did not respond to the appropriate IVIG
regimen or antibiotics and died of severe sepsis.
Amyloidosis
in
a
patient
with
hypo/agammaglobulinemia is extremely rare;
however, recurrent infections as a consequence of
inadequate gammaglobulin substitution therapy,
like in our case, are regarded as the main cause of the
development of amyloidosis (7). Amyloid fibrils are
derived from different protein precursors. The
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amyloidosis was identified after thyroidectomy
material was examined by our pathologist and,
therefore, we used the other primary biopsy sites—
fat, rectum, and bone marrow, which were all
negative, for amyloid staining. Serum amyloid A
protein (SAA), an acute phase reactant, was the
precursor protein in our patient and the case was
secondary amyloidosis caused by longstanding
inflammation (8,11), most probably due to recurrent
bacterial respiratory tract infections during the
course of CVID. The behavior of SAA during
inflammation was comparable with another acute
phase reactant, C-reactive protein (CRP) (8), and
test results showed high titers in our patient’s sera.
The patient was examined for chronic inflammatory
disorders, including rheumatoid arthritis,
tuberculosis, and familial Mediterranean fever—one
of the major causes of secondary amyloidosis in
Turkey (7,10). The patient did not have a history of
FMF and gene mutations for FMF were negative. RF
was negative and no signs or symptoms of
tuberculosis were observed.
In the presented case renal manifestations such
as proteinuria and loss of renal function, and
peripheral and autonomic neuropathy, and
gastrointestinal manifestations such as diarrhea
were not observed. Cardiomyopathy, especially the
restrictive type, was excluded based on
echocardiography. In our case echocardiographic
findings
showed
moderate
pulmonary
hypertension—a chronic pulmonary complication
caused by recurrent respiratory tract infections—
with mild tricuspid regurgitation and right heart
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dilatation, resulting in chronic cor pulmonale,
which was consistent with congestive hepatomegaly
and pedal edema. Electrocardiography showed no
signs of low voltage or pseudo-anteroseptal
infarction of restrictive cardiomyopathy (12).
Extracellular deposition of amyloid fibrils in
organs and tissues results in loss of organ function
and may cause prominent swelling in affected
organs or tissues (8). Deposition of SAA protein
within the thyroid gland in our patient caused
diffuse enlargement of the gland with pressure
exerted on the trachea and esophagus, but without
loss of function. Immunohistochemistry of the
biopsy samples from the thyroid gland helped us
characterize the type of amyloid by using specific
antibodies.
A stepwise approach to patients with systemic or
localized amyloidosis requires histological proof of
amyloid, verification of systemic or localized
involvement, and assessment of the particular type
of amyloid and its precursor to complete the clinical
evaluation necessary for assessment of the prognosis
and therapeutic course.
Herein we discussed the association between
CVID and secondary (AA) amyloidosis restricted to
one organ, thyroid gland, which is an uncommon
site for amyloid deposition. In AA amyloidosis
treatment is aimed at decreasing SAA serum levels
to normal basal values (< 3 mg/l). This aim can only
be achieved with complete suppression or
eradication of the underlying chronic inflammation
(8).
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